

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : L-Arginine Hydrochloride API
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Details : Arginine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus, Type 2.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
October 19, 2012
Lead Product(s) : L-Arginine Hydrochloride API
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable

Contact Us!